Scandion Oncology A/S (OSTO:SCOL) Ending Cash Position : kr25.74 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Scandion Oncology A/S Ending Cash Position?

Scandion Oncology A/S's Ending Cash Position for the quarter that ended in Mar. 2024 was kr25.74 Mil.

Scandion Oncology A/S's quarterly Ending Cash Position declined from Sep. 2023 (kr57.63 Mil) to Dec. 2023 (kr39.80 Mil) and declined from Dec. 2023 (kr39.80 Mil) to Mar. 2024 (kr25.74 Mil).

Scandion Oncology A/S's annual Ending Cash Position declined from Dec. 2021 (kr146.01 Mil) to Dec. 2022 (kr114.68 Mil) and declined from Dec. 2022 (kr114.68 Mil) to Dec. 2023 (kr39.80 Mil).

Scandion Oncology A/S Ending Cash Position Historical Data

The historical data trend for Scandion Oncology A/S's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scandion Oncology A/S Ending Cash Position Chart

Scandion Oncology A/S Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

21.64

7.95

146.01

114.68

39.80

Scandion Oncology A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															90.69	71.63	57.63	39.80	25.74

Scandion Oncology A/S Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Scandion Oncology A/S's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	116.469	+	-76.668
	=	39.80

Scandion Oncology A/S's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	40.251	+	-14.516
	=	25.74

Scandion Oncology A/S Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Scandion Oncology A/S's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Scandion Oncology A/S (OSTO:SCOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandion Oncology A/S (OSTO:SCOL) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

8VY:Germany

Address

Fruebjergvej 3, Symbion, Copenhagen, DNK, 2100

Website

https://www.scandiononcology.com

Scandion Oncology A/S is a clinical-stage biotechnology company developing first-in-class medicines aimed at treating cancer that is resistant to current treatment options. Cancer Drug Resistance Company discovers and develops first-in-class medicines aimed at treating cancer that is resistant to current treatment options.

Scandion Oncology A/S (OSTO:SCOL) Headlines

No Headlines